CAPE COD
2023
Hydrocortisone in Severe Community-Acquired Pneumonia
In 800 ICU patients with severe community-acquired pneumonia, continuous hydrocortisone 200 mg/day, tapered after day 4 reduced 28-day mortality compared with placebo.
Result
- Absolute difference
- 5.7 points
- NNT
- 18
absolute difference-5.6P = 0.006
Absolute difference and NNT are derived from the event rates.
Also reported: Lower intubation (HR 0.77) and vasopressor need.
- Subtopic
- Steroids in severe CAP
- Design
- Multicentre RCT, France
- Relevance
- Important: one of several pillars.
- Source
- Dequin PF, et al. N Engl J Med. 2023;388(21):1931-1941.doi 10.1056/NEJMoa2215145
Discussion & critique
Established hydrocortisone in severe CAP requiring ICU care; reshapes ATS/IDSA/ERS guidance.